3 US Penny Stocks With Market Caps Over $40M To Consider

U.S. stocks have shown resilience as the Nasdaq Composite leads a market rally, with investors brushing off tariff threats and focusing on growth opportunities. For those looking beyond major indices, penny stocks—typically representing smaller or newer companies—continue to offer intriguing prospects despite their historical connotations. While the term might seem outdated, the potential for growth remains significant, especially when these companies boast strong financials and clear growth paths.

Top 10 Penny Stocks In The United States

Name	Share Price	Market Cap	Financial Health Rating
BAB (OTCPK:BABB)	$0.88875	$6.46M	★★★★★★
QuantaSing Group (NasdaqGM:QSG)	$3.08	$125.23M	★★★★★★
Golden Growers Cooperative (OTCPK:GGRO.U)	$4.50	$67.38M	★★★★★★
Imperial Petroleum (NasdaqCM:IMPP)	$2.94	$89.18M	★★★★★★
North European Oil Royalty Trust (NYSE:NRT)	$4.71	$43.29M	★★★★★★
Permianville Royalty Trust (NYSE:PVL)	$1.42	$46.86M	★★★★★★
BTCS (NasdaqCM:BTCS)	$2.69	$46.67M	★★★★★★
Smith Micro Software (NasdaqCM:SMSI)	$1.41	$25.01M	★★★★★☆
CBAK Energy Technology (NasdaqCM:CBAT)	$0.8834	$79.45M	★★★★★☆
Safe Bulkers (NYSE:SB)	$3.60	$384.4M	★★★★☆☆

Click here to see the full list of 709 stocks from our US Penny Stocks screener.

Let's explore several standout options from the results in the screener.

Dyadic International (NasdaqCM:DYAI)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Dyadic International, Inc. is a biotechnology platform company that develops, produces, and sells enzymes and other proteins both in the United States and internationally, with a market cap of $48.53 million.

Operations: The company's revenue segment is derived entirely from its biotechnology business, generating $3.36 million.

Market Cap: $48.53M

Dyadic International, Inc. is a biotechnology company with a market cap of US$48.53 million and revenue of US$3.36 million, indicating it does not have meaningful revenue yet. Despite being unprofitable, the company has reduced its losses over the past five years by 3.7% annually and maintains more cash than debt, offering some financial stability with short-term assets exceeding liabilities. However, its negative return on equity and increasing weekly volatility highlight ongoing challenges in achieving profitability or stable growth in the near term. Recent conference presentations suggest active engagement within the biotech community to potentially bolster future prospects.

• Unlock comprehensive insights into our analysis of Dyadic International stock in this financial health report.
• Explore Dyadic International's analyst forecasts in our growth report.

Newegg Commerce (NasdaqCM:NEGG)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Newegg Commerce, Inc. is an electronics-focused e-retailer operating in the United States, Canada, and internationally with a market cap of approximately $171.81 million.

Operations: The company generates revenue of $1.39 billion from its online retail segment.

Market Cap: $171.81M

Newegg Commerce, Inc., with a market cap of US$171.81 million and revenue of US$1.39 billion, remains unprofitable but shows financial resilience through reduced debt levels and adequate short-term asset coverage over liabilities. Despite a negative return on equity and increasing losses over the past five years, Newegg maintains a stable weekly volatility and has sufficient cash runway for over three years if current free cash flow trends persist. Recent product announcements, including NVIDIA's RTX 50 Series GPUs launch, position Newegg to potentially capitalize on high-demand tech markets while leveraging its experienced management team to navigate ongoing challenges.

• Navigate through the intricacies of Newegg Commerce with our comprehensive balance sheet health report here.
• Assess Newegg Commerce's previous results with our detailed historical performance reports.

Paysign (NasdaqCM:PAYS)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Paysign, Inc. offers prepaid card programs, patient affordability solutions, digital banking services, and integrated payment processing for businesses, consumers, and government entities with a market cap of $141.37 million.

Operations: The company's revenue is primarily generated from data processing, amounting to $56.47 million.

Market Cap: $141.37M

Paysign, Inc., with a market cap of US$141.37 million and revenue of US$56.47 million, is debt-free and has strong asset coverage over its liabilities. Despite a forecasted earnings decline of 17.6% annually over the next three years, Paysign's recent significant earnings growth of 420.5% highlights its potential in the financial sector. The company boasts high-quality past earnings with improved profit margins from 3.5% to 14.3%, supported by an experienced management team averaging 4.7 years in tenure and a seasoned board with an average tenure of 6.8 years, contributing to stable weekly volatility at 7%.

• Jump into the full analysis health report here for a deeper understanding of Paysign.
• Review our growth performance report to gain insights into Paysign's future.

Make It Happen

• Gain an insight into the universe of 709 US Penny Stocks by clicking here.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com